Table 1 Baseline characteristics between high CV and low CV groups
Variables | Low CV (n = 12,967) | High CV (n = 12,966) | p |
|---|---|---|---|
Age (years) | 63.6 ± 10.4 | 61.5 ± 10.2 |  < .01 |
Male (n, %) | 6353 (49.0) | 7108 (54.8) |  < .01 |
BMI (kg/m2) | 25.1 ± 10.7 | 25.0 ± 7.3 | 0.45 |
Current smoker (n, %) | 757 (5.8) | 1078 (8.3) |  < .01 |
Alcohol drinking (n, %) | 854 (6.6) | 1265 (9.8) |  < .01 |
Systolic BP (mmHg) | 120.3 ± 10.1 | 120.6 ± 10.1 | 0.10 |
Diastolic BP (mmHg) | 74.2 ± 5.6 | 74.6 ± 5.6 |  < .01 |
Hypertension (n, %) | 8196 (63.2) | 8104 (62.5) | 0.24 |
Anti-hypertensive drug (n, %) | 7108 (54.8) | 6899 (53.2) | 0.01 |
Dyslipidemia (n, %) | 8697 (67.1) | 9767 (75.3) |  < .01 |
Statin (n, %) | 5634 (43.5) | 5555 (42.8) | 0.33 |
TG-lowering drug (n, %) | 163 (1.1) | 640 (4.9) |  < .01 |
Chronic kidney disease (n, %) | 2760 (21.3) | 2928 (22.6) | 0.01 |
Insulin use (n, %) | 3099 (23.9) | 3685 (28.4) |  < .01 |
Antiplatelet drug (n, %) | 4753 (36.7) | 4678 (36.1) | 0.34 |
Anticoagulant (n, %) | 227 (1.8) | 245 (1.9) | 0.40 |
Glucose (mg/dL) | 134.6 ± 32.8 | 138.9 ± 36.2 |  < .01 |
HbA1c (%) | 7.1 ± 1.2 | 7.2 ± 1.2 |  < .01 |
Creatinine (mg/dL) | 1.15 ± 1.03 | 1.32 ± 1.46 |  < .01 |
hsCRP (mg/dL) | 3.1 ± 2.9 | 3.4 ± 3.0 |  < .01 |
Total cholesterol (mg/dL) | 171.7 ± 31.1 | 174.0 ± 32.9 |  < .01 |
LDL-cholesterol (mg/dL) | 101.3 ± 26.5 | 99.9 ± 28.3 |  < .01 |
HDL-cholesterol (mg/dL) | 48.2 ± 11.8 | 46.5 ± 11.4 |  < .01 |
Triglyceride (mg/dL) | 140.7 ± 70.5 | 180.7 ± 99.3 |  < .01 |
TG-CV (%) | 20.8 ± 6.5 | 46.6 ± 15.9 |  < .01 |
TG-CEE (arbitrary unit) | 5061.8 ± 1918.3 | 6173.0 ± 2679.2 |  < .01 |
Number of TG measurement | 5.9 ± 3.6 | 6.6 ± 4.2 |  < .01 |
Interval between TG measurement (day) | 221.5 ± 131.7 | 203.5 ± 126.2 |  < .01 |